We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
2 Aspiriant Mutual Funds to Consider for Your Portfolio
Read MoreHide Full Article
Aspiriant is an independent wealth management firm based in Los Angeles, CA. The firm was formed in 2008 through the merger of two existing companies, Kochis Fitz (founded in San Francisco in 1991) and Quintile Wealth Management (founded in Los Angeles in 2002).
Aspiriant’s mutual funds differ by strategy, including asset allocation, market exposure and investment risk. Each Aspiriant mutual fund has its own investment objectives, portfolio composition and risk characteristics, making it a diversified investment option.
We have picked two Aspiriant mutual funds — Aspiriant Risk-Managed Equity Allc Adv (RMEAX - Free Report) and Aspiriant Risk-Managed Municipal Bond (RMMBX - Free Report) — which investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or Rank 2 (Buy), with positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Aspiriant Risk-Managed Equity Allc Adv fund invests its net assets (plus borrowings) in equity securities, including common and preferred stock and depositary receipts, and may use rights, warrants, and investment company shares.
John Allen has been the lead manager of RMEAX since Oct. 31, 2015. Most of the fund’s holdings were in companies such as GMO Quality VI. (34.5%), Schwab Fundamental US Large Company Idx (7.2%) and Baillie Gifford Emerging Markets Eqs (5.7%) as of June 30, 2026.
RMEAX’s 3-year and 5-year annualized returns are 16.2% and 8.9%, respectively. Its net expense ratio is 0.29%. RMEAX has a Zacks Mutual Fund Rank #2.
To see how this fund performed compared to its category, and other 1 (Strong Buy) and 2 Ranked Mutual Funds, please click here.
Aspiriant Risk-Managed Municipal Bond fund invests its total assets in municipal securities whose income is exempt from regular federal income tax, including obligations issued by U.S. states and their subdivisions, authorities, instrumentalities, and corporations, as well as obligations issued by U.S. territories.
Paul L. Brennan has been the lead manager of RMMBX since July 1, 2015. Most of the fund’s holdings were in companies such as Miscellaneous Bonds (12.9%), Other (7.5%) and Cash (6.8%) as of March 31, 2026.
RMMBX’s 3-year and 5-year annualized returns are 3.1% and 0.2%, respectively. Its net expense ratio is 0.34%. RMMBX has a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Image: Bigstock
2 Aspiriant Mutual Funds to Consider for Your Portfolio
Aspiriant is an independent wealth management firm based in Los Angeles, CA. The firm was formed in 2008 through the merger of two existing companies, Kochis Fitz (founded in San Francisco in 1991) and Quintile Wealth Management (founded in Los Angeles in 2002).
Aspiriant’s mutual funds differ by strategy, including asset allocation, market exposure and investment risk. Each Aspiriant mutual fund has its own investment objectives, portfolio composition and risk characteristics, making it a diversified investment option.
We have picked two Aspiriant mutual funds — Aspiriant Risk-Managed Equity Allc Adv (RMEAX - Free Report) and Aspiriant Risk-Managed Municipal Bond (RMMBX - Free Report) — which investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or Rank 2 (Buy), with positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Aspiriant Risk-Managed Equity Allc Adv fund invests its net assets (plus borrowings) in equity securities, including common and preferred stock and depositary receipts, and may use rights, warrants, and investment company shares.
John Allen has been the lead manager of RMEAX since Oct. 31, 2015. Most of the fund’s holdings were in companies such as GMO Quality VI. (34.5%), Schwab Fundamental US Large Company Idx (7.2%) and Baillie Gifford Emerging Markets Eqs (5.7%) as of June 30, 2026.
RMEAX’s 3-year and 5-year annualized returns are 16.2% and 8.9%, respectively. Its net expense ratio is 0.29%. RMEAX has a Zacks Mutual Fund Rank #2.
To see how this fund performed compared to its category, and other 1 (Strong Buy) and 2 Ranked Mutual Funds, please click here.
Aspiriant Risk-Managed Municipal Bond fund invests its total assets in municipal securities whose income is exempt from regular federal income tax, including obligations issued by U.S. states and their subdivisions, authorities, instrumentalities, and corporations, as well as obligations issued by U.S. territories.
Paul L. Brennan has been the lead manager of RMMBX since July 1, 2015. Most of the fund’s holdings were in companies such as Miscellaneous Bonds (12.9%), Other (7.5%) and Cash (6.8%) as of March 31, 2026.
RMMBX’s 3-year and 5-year annualized returns are 3.1% and 0.2%, respectively. Its net expense ratio is 0.34%. RMMBX has a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>